neoadjuvant nalirifox - SERP Analysis

https://www.ejcancer.com/article/S0959-8049(23)00732-3/fulltext

https://pubmed.ncbi.nlm.nih.gov/37753702/

https://clinicaltrials.gov/study/NCT07020468?aggFilters=phase%3A0%2B1%2B2%2B3%2B4%2Cstatus%3Anot%2Brec%2Bact%2Benr%2CstudyType%3Aint&primComp=2020-01-01_&lastUpdPost=2024-11-08_

https://pmc.ncbi.nlm.nih.gov/articles/PMC10594143/

https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2023-04160

https://www.mskcc.org/cancer-care/clinical-trials/23-027

https://www.onclive.com/view/patient-factors-toxicities-key-to-selecting-nalirifox-or-other-chemo-options-in-advanced-pancreatic-cancer

https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS619

https://www.asco.org/abstracts-presentations/ABSTRACT433568

https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.e16447

https://www.sciencedirect.com/science/article/pii/S0959804923007323

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2813517

https://connect.careboxhealth.com/en-US/trial/listing/575425

https://www.cancer.gov/research/participate/clinical-trials/intervention/pegylated-liposomal-irinotecan

https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/2024/10000/fda_endorses_nalirifox_for_metastatic_pancreatic.7.aspx

https://www.centerwatch.com/clinical-trials/listings/NCT06816914/perioperative-nalirifox-liposomal-irinotecan-in-combination-with-fluorouracil-leucovorin-and-oxaliplatin-in-resectable-pancreatic-adenocarcinoma-randomized-phase-ii-trial

https://ctv.veeva.com/study/neoadjuvant-therapy-nalirifox-for-locally-advanced-colon-and-upper-rectal-cancer

https://ascopost.com/issues/february-25-2023/first-line-nalirifox-improves-survival-in-metastatic-pancreatic-cancer/

https://www.researchgate.net/publication/374254011_A_phase_II_study_of_neoadjuvant_liposomal_irinotecan_with_5-FU_and_oxaliplatin_NALIRIFOX_in_pancreatic_adenocarcinoma

https://www.jneonatalsurg.com/index.php/jns/article/view/2383

https://www.cancernetwork.com/view/nalirifox-in-practice-treatment-strategies-for-patients-with-mpdac

https://clin.larvol.com/abstract-detail/ASCO-GI%202025/73923624

https://www.asco.org/abstracts-presentations/ABSTRACT424054

https://www.mdpi.com/2072-6694/16/13/2423

https://www.npcf.us/clinical-trials/stereotactic-body-radiation-therapy-followed-by-nalirifox-vs-nalirifox-for-borderline-resectable-pancreatic-cancer/

https://www.themednet.org/in-what-situations-if-any-would-you-recommend-nalirifox-over-folfirinox-for-first-line-treatment-of-patients-with-unresectable-pancreatic-cancer

https://www.cancernetwork.com/view/frontline-nalirifox-approved-by-fda-in-metastatic-pdac

https://www.chictr.org.cn/showprojEN.html?proj=230263

https://www.researchgate.net/publication/388608558_Phase_II_study_of_neoadjuvant_NALIRIFOX_followed_by_chemoradiation_with_paclitaxel_and_carboplatin_in_locally_advanced_gastroesophageal_cancer

https://oncologytube.com/napoli-3-trial-nalirifox-2023-slides-chung-md-moasc/

https://www.onclive.com/view/first-line-nalirifox-demonstrates-survival-advantage-over-standard-gemcitabine-paclitaxel-in-metastatic-pdac

https://ecancer.org/en/video/12374-characteristics-associated-with-longer-term-os-with-nalirifox-regimen-in-metastatic-pancreatic-adenocarcinoma

https://www.mdpi.com/2072-6694/16/9/1632

https://m.x-mol.net/paper/detail/1884451462158311424

https://ascopost.com/news/january-2023/first-line-nalirifox-regimen-improves-overall-survival-in-metastatic-pancreatic-cancer/

https://www.npcf.us/clinical-trials/nalirifox-before-surgery-for-the-treatment-of-borderline-resectable-pancreatic-ductal-adenocarcinoma-nectar-trial/

https://www.cancertherapyadvisor.com/reports/nalirifox-pdac-untreated-metastatic-new-reference-regimen/

https://fdaaa.trialstracker.net/trial/NCT06821997/

https://ctv.veeva.com/study/a-study-of-nalirifox-in-combination-with-radiation-therapy-in-people-with-pancreatic-ductal-adenocar

https://discovery.researcher.life/article/a-real-world-study-of-the-nalirifox-regimen-in-perioperative-treatment-of-borderline-resectable-and-locally-advanced-pancreatic-cancer-in-china/d10573683ef4335ea031d787d82ea73f

https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-025-03867-2

https://www.sciencedirect.com/science/article/pii/S0959804924008505

https://europepmc.org/article/med/33957442

https://www.eviq.org.au/medical-oncology/upper-gastrointestinal/pancreas-and-biliary/3387-pancreas-metastatic-irinotecan-nanoliposomal

https://delta.larvol.com/Institutions/dcd8c77d1cf34f2ea2864b76755e93c3/Ipsen/3/7711bdcf246e4635aeb932f6e25c04dc/HOPE-Neoadjuvant-Therapy-NALIRIFOX-for-Locally-Advanced-Colon-and-Upper-Rectal-Cancer/

https://www.gioncologynow.com/post/clinical-profile-of-long-term-survivors-may-be-informative-for-treatment-in-metastatic-pancreatic-cancer

https://m.x-mol.net/paper/detail/1928624630183895040

https://www.nature.com/subjects/pancreatic-cancer/nrclinonc

https://ecancer.org/en/browse?category_child=19&template=basic

https://www.hmpgloballearningnetwork.com/site/onc/videos/first-line-nalirifox-conveys-survival-benefits-metastatic-pancreatic-ductal

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01613-x

https://mednexus.org/doi/10.1097/JP9.0000000000000091

https://letswinpc.org/category/research/chemotherapy/page/2/

https://emedicine.medscape.com/article/280605-treatment

https://www.vumedi.com/video/optimizing-patient-selection-for-1l-nalirifox-treatment-in-mpdac-who-is-the-right-patient/

https://www.uchicagomedicine.org/find-a-clinical-trial/clinical-trial/cirb242043

https://www.wjgnet.com/1948-9366/full/v16/i5/1223.htm

https://onlinelibrary.wiley.com/doi/abs/10.1002/jso.28003

https://www.annalsofoncology.org/article/S0923-7534(23)00824-4/fulltext

https://air.unimi.it/retrieve/9b54b807-8b00-4e24-95be-0fab14aedff1/nichetti_2024_oi_231482_1708545035.59852.pdf

https://dailyreporter.esmo.org/esmo-congress-2023/gastrointestinal-cancers/new-treatment-paradigms-may-offer-advances-in-pancreatic-cancer-treatments

https://www.eviq.org.au/medical-oncology/upper-gastrointestinal/pancreas-and-biliary/3387-pancreas-metastatic-irinotecan-nanoliposomal/patient-information

https://www.chictr.org.cn/showprojEN.html?proj=230650

https://www.targetedonc.com/view/paradigm-pivots-in-neoadjuvant-direction-expert-insights-on-world-pancreatic-cancer-day

https://www.reddit.com/r/pancreaticcancer/comments/1ikejz6/first_follow_up_scans/

https://letswinpc.org/research/asco-2023-research-update/

https://pdfs.semanticscholar.org/aec4/6ffe9d1a0d75effbd565c3b411795c0d1c41.pdf

https://emedicine.medscape.com/article/2007067-overview

https://journals.lww.com/jpancreatology/fulltext/2023/12000/initial_chemotherapy_option_for_pancreatic_ductal.7.aspx

https://ecancer.org/en/video/10654-neoadjuvant-immunotherapy-improves-outlook-in-high-risk-melanoma

https://ecancer.org/en/video/10974-loco-regional-management-after-neoadjuvant-chemotherapy

https://www.oncnursingnews.com/view/proactive-management-of-nalirifox-related-diarrhea-is-crucial-in-metastatic-pdac

https://www.vumedi.com/video/asco-gi-2023-napoli-3-randomized-open-label-phase-3-study-liposomal-irinotecan-5-fluorouracilleucovo/

https://www.targetedonc.com/view/prospect-neoadjuvant-therapy-for-locally-advanced-rectal-cancer

https://www.geneonline.com/research-explores-chemotherapy-immunotherapy-integration-and-resistance-mechanisms-in-nsclc-treatment/

https://www.cancernursingtoday.com/post/beyond-the-headlines-understanding-nalirifox-and-its-significance-in-pancreatic-cancer-treatment

https://www.themednet.org/in-a-patient-with-low-risk-t3n1-stage-iii-colon-cancer-unable-to-tolerate-capox-due-to-profound-gi-toxicity-would-you-switch-to-folfox-and-extend-to-6-months-of-adjuvant-therapy

https://www.oncnursingnews.com/view/liposomal-irinotecan-oxaliplatin-dose-reduction-may-not-affect-survival-in-metastatic-pdac

https://www.vumedi.com/video/perspectives-on-the-recent-fda-approval-of-nalirifox-in-frontline-metastatic-pancreatic-cancer/

https://ecancer.org/en/video/5561-neoadjuvant-abemaciclib-for-hr-positive-her-negative-breast-cancer

https://news.cancerconnect.com/pancreatic-cancer/onivyde-approved-for-pancreatic-cancer

https://www.vumedi.com/video/2023-esmo-wcgic-insights-additional-results-from-the-phase-3-napoli-3-trial-nalirifox-vs-nab-paclita/

https://ecancer.org/en/video/11324-prognostic-value-of-her2-low-status-in-breast-cancer-a-systematic-review-and-meta-analysis

https://www.geneonline.com/takeda-president-giles-platford-discusses-advancing-plasma-derived-therapies-and-addressing-supply-chain-challenges/

https://www.drugs.com/nalirifox.html

https://pancan.org/news/fda-approves-new-first-line-treatment-option-for-metastatic-pancreatic-cancer-what-you-need-to-know/